Methicillin-Resistant Staphylococcus aureus (MRSA): Prevalence and Antimicrobial Sensitivity Pattern among Outdoor and Indoor Patients Dhaka City Hospital Bangladesh

Md. Ashiqur Rahman¹, Kohinoor Akter Raton¹ and Md. Asif Hossain^2,

¹Department of Microbiology, Dr. Sirajul Islam Medical College & Hospital Ltd, Dhaka, Bangladesh

²Department of Microbiology, BIRDEM General Hospital, Dhaka, Bangladesh

Cite this paper:
Md. Ashiqur Rahman, Kohinoor Akter Raton and Md. Asif Hossain. Methicillin-Resistant Staphylococcus aureus (MRSA): Prevalence and Antimicrobial Sensitivity Pattern among Outdoor and Indoor Patients Dhaka City Hospital Bangladesh. American Journal of Microbiological Research. 2021; 9(1):9-13. doi: 10.12691/ajmr-9-1-2

Abstract

Methicillin-Resistant S. aureus (MRSA) is one of the significant pathogens with associated public-health concern in the world. The present study has been focused on the prevalence of MRSA and their antibiotic resistance of indoor and outdoor patients different age & gender in clinical history, Dr. Sirajul Islam medical college and hospital Dhaka, Bangladesh. We were performed during the period of January 2019 to July 2019. A total 964 samples which is outdoor 354 (36.72%) indoor 610 (63.27%). We were observation 5 days (BACTEC-9050 Machine) then inoculated selective onto Blood agar media and the culture plates were incubated at 37°C for 24 h. The S. aureus colonies showing golden yellow colour on Blood agar were primarily identified as S. aureus, which were then subjected for catalase and coagulase tests. The Methicillin-Resistant S. aureus (MRSA) could be detected outdoor and indoor patients only 42 (4.35%) into, males 18 and female 24 in total sample, on the other hand S. aureus. (MSSA) 50 (5.18%), Pseudomonas spp. 14 (1.45%), Klebsiella spp. 13 (1.34%), Salmonella spp. 27 (2.80%), E. coli 21 (2.17%), no MRSA, MSSA and other organisms are found 797 (82.67%). Total identified MRSA Staphylococci aureus. 42 (4%) in all blood samples, and other 922 (96%). Standard antimicrobial disks representing multiple sixteen drug were, Sensitive-381 (56.69%), Resistance-284 (42.26%), as well as Intermediate-7 (1.04%) against antibiotics, Oxacillin, Vancomycin, Erythromycin, Co-trimoxazole, Ciprofloxacin, Gentamicin, Linezolid, Amoxicillin, Amoxyclave, Azithromycin, Imipenem, Meropenem, Netilmicin, Gatifloxacin, Cloxacillin, Sparfloxacin. In this study, we describe the current burden of MRSA infections in healthcare and community of Bangladesh. And settings across other country the main threats caused by recent changes in the epidemiology of MRSA. This data has important implication for quality of patients care antibiotic selection and infection control practices.

Keywords:
Methicillin-Resistance Staphylococcus aureus hospital indoor outdoor patients blood antimicrobial sensitivity

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Wey Wen Lima, Peng Wua,, Helen S. Bonda, Jessica Y. Wonga, Kaiwen Nia, Wing Hong Setoa, Mark Jita,b,c , Benjamin J. Cowlinga. Determinants of methicillin-resistant Staphylococcus aureus (MRSA) prevalence in the Asia-Pacific region: A systematic review and meta-analysis. 2018. International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd.
[2]	Shamweel Ahmad, Mehr-un-Nisa Muhammad Mustafa and Hiba Shamweel. October 2017. Methicillin Resistant Staphylococcus aureus (MRSA) a Challenge for Health Care- Professionals and Patients. https://www.actascientific.com/ASPS/pdf/ASPS-01-0024.pdf.
[3]	Marina Salas, Maciej Wernecki , Lucía Fernández, Beatriz Iglesias, Diana Gutiérrez, Andrea Álvarez, Laura García, Elisabeth Prieto,Pilar García and Ana Rodríguez. Characterization of Clinical MRSA Isolates from Northern Spain and Assessment of Their Susceptibility to Phage-Derived Antimicrobials.
[4]	Mireille Goetghebeur PhD, Pierre-Alexandre Landry PhD, Donald Han, Colin Vicente MSc. (January/February 2007) Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences.
[5]	Isa Adamu Gulani, Yaqub Ahmed Geidam, Lawan Adamu, J. R. Lawal and Falmata Ali Abadam. June 2016. Prevalence and phenotypic detection of methicillin resistance Staphylococcus aureus between ruminants butchered for humanoid intake and animal handlers in Maiduguri, Nigeria. Journal of Advanced Veterinary and Animal Research Original Article. Vol 3 No 2, Pages 152-159.
[6]	Eyob Yohaness Garoy, Yacob Berhane Gebreab, Oliver Okoth Achila, Daniel Goitom Tekeste, Robel Kesete, Robel Ghirmay, Ruta Kiflay, and Thomas Tesfu. Methicillin-Resistant Staphylococcus aureus (MRSA): Prevalence and Antimicrobial Sensitivity Pattern among Patients—a Multicenter Study in Asmara, Eritrea. Hindawi Canadian Journal of Infectious Diseases and Medical Microbiology Volume 2019, Article ID 8321834, 9 pages.
[7]	Mohammad Aminul Islam, Sahana Parveen, Mahdia Rahman, Mohsina Huq, Ashikun Nabi, Zahed Uddin Mahmood Khan, Niyaz Ahmed and Jaap A. Wagenaar, (March 2019) Occurrence and Characterization of Methicillin Resistant Staphylococcus aureus in Processed Raw Foods and Ready-to-Eat Foods in an Urban Setting of a Developing Country.
[8]	Simone G. Souza, Guilherme B. Campos, Pollianna S. Oliveira, Daniel S. Sousa, Danilo C. C. Da Silva, Verena M. Santos, Aline T. Amorim, Angelita M. O. G. Santos, Jorge Timenetsky, Mariluze P. Cruz, Regiane Yatsuda, Lucas M. Marques. Virulence Factors in Methicillin-Resistant Staphylococcus aureus isolated from ICU Units in Brazil.
[9]	Robert Gallagher, Noboru Motohashi, Anuradha Vanam, Rao Gollapudi. (April 2017) Global methicillin-resistant Staphylococcus aureus (MRSA) infections and current research trends.
[10]	R Köck1,2, K Becker2, B Cookson3, J E van Gemert-Pijnen4, S Harbarth5,6, J Kluytmans7,8, M Mielke9, G Peters2, R L Skov10, M J Struelens 11,12, E Tacconelli13, A Navarro Torné12, W Witte14, A W Friedrich. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. See discussions, stats, and author profiles for this https://www.researchgate.net/publication/47509253.
[11]	D. E. Redziniak 1, D. R. Diduch 2, K. Turman 2, J. Hart 2, T. L. Grindstaff 3, J. M. MacKnight 4, D. J Mistry 4. Methicillin-resistant Staphylococcus aureus (MRSA) in the Athlete. https://www.researchgate.net/publication/26240485.
[12]	C.-J. Chen and Y.-C. Huang. New epidemiology of Staphylococcus aureus infection in Asia. https://www.ncbi.nlm.nih.gov/pubmed/24888414.
[13]	Ali Al Bshabshe,Martin R. P. Joseph, Amgad A. Awad El-Gied, Abdalla N. Fadul, Clinical Relevance and Antimicrobial Profiling of Methicillin-Resistant Staphylococcus aureus (MRSA) on Routine Antibiotics and Ethanol Extract of Mango Kernel (Mangifera indica L.)Volume 2020 |ArticleID 4150678.
[14]	Jonathan WH Wong,1 Margaret Ip,2 Arthur Tang,3 Vivian WI Wei,1 Samuel YS Wong,1 Steven Riley,4 Jonathan M Read,5,6, Kin on Kwok. Prevalence and risk factors of community associated methicillin-resistant Staphylococcus aureus carriage in Asia-Pacific region from 2000 to 2016: a systematic review and meta-analysis. www.dovepress.com.
[15]	Pimonwan Phokhaphan, Pholawat Tingpej, Anucha Apisarnthanarak and Sumalee Kondo. Prevalence and antibiotic susceptiblity of methicillin resistant staphylococcus aureus collected at thammasat university hospital, thailand, August 2012 - July 2015. vol 48 No. 2 March 2017. https://www.tm.mahidol.ac.th/seameo/2017-48-2/09-7054-18-351-359.pdf.
[16]	Bidya Shrestha. Comparative prevalence of MRSA in two Nepalese tertiary care hospitals. Open Journal of Clinical Diagnostics, 2013, 3, 67-73 OJCD.
[17]	Panagiotis Papadopoulos a, Theofilos Papadopoulos b, Apostolos S. Angelidis c , Evridiki Boukouvala b , Antonios Zdragas b , Anna Papa d , Christos Hadjichristodoulou e , Daniel Sergelidis a. Prevalence of Staphylococcus aureus and of methicillin-resistant S. aureus (MRSA) along the production chain of dairy products in north-western Greece. Food Microbiology 69 (2018) 43e50. See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/318760900.
[18]	Clinical and Laboratory Standards Institute (CLSI), 2009. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically M7-A8. CLSI, Wayne, PA.
[19]	Clinical and Laboratory Standards Institute, Performance Standard testing, Update Jun 2018, CLIS, Wayne, PA 19087 USA.
[20]	Frank R DeLeo, Michael Otto, Barry N Kreiswirth, Henry F Chambers. Community-associated meticillin-resistant Staphylococcus aureus. Published Online March 5, 2010 https://www.ncbi.nlm.nih.gov/pubmed/20206987.
[21]	Pallab Ray, Vikas Gautam and Rachna Singh. Methicillin-resistant Staphylococcus aureus (MRSA) in developing and developed countries: implications and solutions. http://origin.searo.who.int/publications/journals/regional_health_f orum/media/2011/V15n1/rhfv15n1p1.pdf.